Market Overview

Avalanche Biotechnologies (AAVL) Plummets on Q2 Loss


Avalanche Biotechnologies Inc (NASDAQ: AAVL) shares dropped 28.2% to $9.93. Avalanche reported a Q2 loss of $0.38 per share on revenue of $279,000 and issued an update on AVA-101 program. Share volume was 774,000, compared to an all-day average of 201,000


Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo